FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045708728> ?p ?o ?g. }

• W3045708728 endingPage "1183" @default.
• W3045708728 startingPage "1175" @default.
• W3045708728 abstract "Abstract Aim Peripheral features contribute to disease burden in ankylosing spondylitis (AS). This study investigated the frequency of peripheral disease and effectiveness of adalimumab among Korean patients with AS. Methods Peripheral disease was evaluated in consecutively enrolled patients with active AS (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] score ≥ 4). An adult subpopulation was subsequently enrolled in a prospective, observational study and received adalimumab 40 mg, every 2 weeks. During a 52‐week follow‐up, AS disease activity was assessed by BASDAI score, and effectiveness in peripheral disease assessed via changes in Maastricht Ankylosing Spondylitis Enthesitis Score (MASES; 0‐13), swollen joint and tender joint counts (SJC, 0‐44; TJC, 0‐46), and dactylitic digits from baseline. Results Of 1161 Korean patients with AS, 178 (15.3%) and 306 (26.4%) had enthesitis and peripheral arthritis, respectively; dactylitis was diagnosed in 28 patients (2.4%). Of 201 patients enrolled in the observational study, 46.3%, 33.3%, and 3.0% had enthesitis, peripheral arthritis, and dactylitis, respectively. Overall, 75.1% of patients achieved >50% improvement in BASDAI score by week 12. Mean MASES was significantly reduced from 2.67 at baseline to 0.85 and 0.34 at weeks 12 and 52, respectively ( P < .0001). Similarly, SJC and TJC improved significantly from 2.58 and 3.49 at baseline to 0.80 and 1.68, respectively, by week 12 ( P < .0001). Dactylitis was resolved in all affected patients by week 28. Conclusion Of these Korean patients with AS, those who received adalimumab demonstrated higher prevalence for peripheral symptoms and, subsequently, adalimumab treatment improved peripheral features of their AS." @default.
• W3045708728 created "2020-08-03" @default.
• W3045708728 creator A5001967366 @default.
• W3045708728 creator A5017661583 @default.
• W3045708728 creator A5025745982 @default.
• W3045708728 creator A5025943063 @default.
• W3045708728 creator A5026216541 @default.
• W3045708728 creator A5026654916 @default.
• W3045708728 creator A5030248447 @default.
• W3045708728 creator A5030706909 @default.
• W3045708728 creator A5050458041 @default.
• W3045708728 creator A5063486010 @default.
• W3045708728 creator A5064707258 @default.
• W3045708728 creator A5065859718 @default.
• W3045708728 creator A5078775403 @default.
• W3045708728 creator A5079117039 @default.
• W3045708728 date "2020-07-29" @default.
• W3045708728 modified "2023-10-17" @default.
• W3045708728 title "Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab" @default.
• W3045708728 cites W1488490750 @default.
• W3045708728 cites W1565102150 @default.
• W3045708728 cites W1712519246 @default.
• W3045708728 cites W1826046665 @default.
• W3045708728 cites W1967301621 @default.
• W3045708728 cites W1990305566 @default.
• W3045708728 cites W2015406536 @default.
• W3045708728 cites W2026438401 @default.
• W3045708728 cites W2052996963 @default.
• W3045708728 cites W2084560920 @default.
• W3045708728 cites W2097486992 @default.
• W3045708728 cites W2103524303 @default.
• W3045708728 cites W2118943683 @default.
• W3045708728 cites W2119133293 @default.
• W3045708728 cites W2124890503 @default.
• W3045708728 cites W2159212884 @default.
• W3045708728 cites W2166560806 @default.
• W3045708728 cites W2278932593 @default.
• W3045708728 cites W2513052714 @default.
• W3045708728 cites W2530352485 @default.
• W3045708728 cites W2591276563 @default.
• W3045708728 cites W2620369605 @default.
• W3045708728 cites W2776016310 @default.
• W3045708728 cites W2781625338 @default.
• W3045708728 cites W2806852271 @default.
• W3045708728 cites W2893160789 @default.
• W3045708728 doi "https://doi.org/10.1111/1756-185x.13917" @default.
• W3045708728 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8246777" @default.
• W3045708728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32725789" @default.
• W3045708728 hasPublicationYear "2020" @default.
• W3045708728 type Work @default.
• W3045708728 sameAs 3045708728 @default.
• W3045708728 citedByCount "2" @default.
• W3045708728 countsByYear W30457087282022 @default.
• W3045708728 countsByYear W30457087282023 @default.
• W3045708728 crossrefType "journal-article" @default.
• W3045708728 hasAuthorship W3045708728A5001967366 @default.
• W3045708728 hasAuthorship W3045708728A5017661583 @default.
• W3045708728 hasAuthorship W3045708728A5025745982 @default.
• W3045708728 hasAuthorship W3045708728A5025943063 @default.
• W3045708728 hasAuthorship W3045708728A5026216541 @default.
• W3045708728 hasAuthorship W3045708728A5026654916 @default.
• W3045708728 hasAuthorship W3045708728A5030248447 @default.
• W3045708728 hasAuthorship W3045708728A5030706909 @default.
• W3045708728 hasAuthorship W3045708728A5050458041 @default.
• W3045708728 hasAuthorship W3045708728A5063486010 @default.
• W3045708728 hasAuthorship W3045708728A5064707258 @default.
• W3045708728 hasAuthorship W3045708728A5065859718 @default.
• W3045708728 hasAuthorship W3045708728A5078775403 @default.
• W3045708728 hasAuthorship W3045708728A5079117039 @default.
• W3045708728 hasBestOaLocation W30457087281 @default.
• W3045708728 hasConcept C126322002 @default.
• W3045708728 hasConcept C2776260265 @default.
• W3045708728 hasConcept C2777077863 @default.
• W3045708728 hasConcept C2777402515 @default.
• W3045708728 hasConcept C2777453003 @default.
• W3045708728 hasConcept C2778019847 @default.
• W3045708728 hasConcept C2779134260 @default.
• W3045708728 hasConcept C2780131103 @default.
• W3045708728 hasConcept C2780132546 @default.
• W3045708728 hasConcept C46762472 @default.
• W3045708728 hasConcept C71924100 @default.
• W3045708728 hasConcept C90924648 @default.
• W3045708728 hasConceptScore W3045708728C126322002 @default.
• W3045708728 hasConceptScore W3045708728C2776260265 @default.
• W3045708728 hasConceptScore W3045708728C2777077863 @default.
• W3045708728 hasConceptScore W3045708728C2777402515 @default.
• W3045708728 hasConceptScore W3045708728C2777453003 @default.
• W3045708728 hasConceptScore W3045708728C2778019847 @default.
• W3045708728 hasConceptScore W3045708728C2779134260 @default.
• W3045708728 hasConceptScore W3045708728C2780131103 @default.
• W3045708728 hasConceptScore W3045708728C2780132546 @default.
• W3045708728 hasConceptScore W3045708728C46762472 @default.
• W3045708728 hasConceptScore W3045708728C71924100 @default.
• W3045708728 hasConceptScore W3045708728C90924648 @default.
• W3045708728 hasIssue "9" @default.
• W3045708728 hasLocation W30457087281 @default.
• W3045708728 hasLocation W30457087282 @default.
• W3045708728 hasOpenAccess W3045708728 @default.

• next